Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1998-04-28
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544295, 544364, 544373, 544363, 544331, 544292, 514183, 514213, 514308, 514310, 514414, 514416, 514397, 514318, 514323, 514254, 514218, 514272, 514307, 514339, 540476, 540594, 540597, 540596, A61K 31495, A61K 3150, C07D40102, C07D40302
Patent
active
057444722
ABSTRACT:
Disclosed are compounds of the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein the 6-membered A ring may be optionally substituted with up to four groups independently selected from halogen, hydroxy, lower alkyl, or lower alkoxy;
REFERENCES:
patent: 5118704 (1992-06-01), Minaskanian et al.
patent: 5314885 (1994-05-01), Scott et al.
Taubes, (1994), "Will New Dopamine Receptors Offer a Key to Schizophrenia," Science, vol. 265, pp. 1034-1035.
de Costa Brian
He Xiao-Shu
Wasley Jan W. F.
Grumbling Matthew V.
Neurogen Corporation
LandOfFree
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dop does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dop will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1532155